Results 151 to 160 of about 4,221 (205)

Functional Effects of Cyclization on Li1 Peptide Activity against Metacyclic <i>Leishmania amazonensis</i> Internalization. [PDF]

ACS Omega
Reis TC, Yagi ACL, Velásquez AMA, Dias Ramos AL, Costa Coelho NC, Cilli EM, Graminha MAS.   +6 more
europepmc   +1 more source

From Dyes to Drugs? Selective Leishmanicidal Efficacy of Repositioned Methylene Blue and Its Derivatives in In Vitro Evaluation. [PDF]

Biology (Basel)
Vasco-Dos-Santos DR, Almeida-Silva J, Fiuza LFA, Vacani-Martins N, Rocha ZND, Soeiro MNC, Henriques-Pons A, Torres-Santos EC, Vannier-Santos MA.   +8 more
europepmc   +1 more source

Quantitative proteomics of infected macrophages reveals novel Leishmania virulence factors. [PDF]

PLoS Pathog
Hagedorn N, Fradera-Sola A, Mitnacht M, Gold T, Schleicher U, Butter F, Janzen CJ.   +6 more
europepmc   +1 more source

Fifteen-Year Evolution of Chronic Cutaneous Leishmaniasis Mimicking Other Dermatoses. [PDF]

Am J Trop Med Hyg
Hurtado-Rossi L, Gutierrez-Gomez M, Martinez-Valencia AJ, García-Luna JA.   +3 more
europepmc   +1 more source

An Overview of the Factors Related to Leishmania Vaccine Development. [PDF]

Vaccines (Basel)
Passero LFD, Cavallone IN, Araújo Flores GV, de Lima Melchert SS, Laurenti MD.   +4 more
europepmc   +1 more source

Recent advances in structural modifications of natural products for anti-leishmaniasis therapy (2010-2024). [PDF]

RSC Med Chem
Sun FQ, Quan YS, Shen QK, Guo HY, Yin XM, Quan ZS.   +5 more
europepmc   +1 more source

Antibody response induced by structural proteins from <i>Triatoma virus</i> as potential adjuvants in experimental immunisation models. [PDF]

Front Microbiol
Queiroz AMV, do Nascimento Oliveira A, de Deus ARS, de Oliveira IEF, Dos Santos IA, Santos FLN, Celedon PAF, Guérin DMA, Viguera AR, Sousa-Silva M.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

POTENTIATING ACTION OF RIFAMPICIN AND ISONIAZID AGAINST LEISHMANIA MEXICANA AMAZONENSIS

Lancet, The, 1981
The treatment of the complex of diseases known as leishmaniasis, caused by infection with protozoal parasites, is often unsatisfactory. The response to chemotherapy depends not only on the species of infecting Leishmania but also on the immune reactions of the host. This creates difficulties in evaluating any new drug in clinical trials. In a Brazilian
R Lainson, J J Shaw
exaly   +3 more sources

Destruction of Leishmania mexicana amazonensis Promastigotes by Normal Human Serum

American Journal of Tropical Medicine and Hygiene, 1987
Fresh normal human serum was observed to have a lethal effect on Leishmania mexicana amazonensis promastigotes obtained from laboratory-bred Lutzomyia longipalpis or on promastigotes grown in liquid culture medium, inoculated with the same isolates. Heat inactivation abolished the Leishmania lytic activity from the sera.
Manoel Barral-Netto, M R Siopathis, N Lagarde   +2 more
exaly   +3 more sources

Interactions Between Plasmodium Yoelii and Leishmania Mexicana Amazonensis in Leishmania Resistant C57B1/6 Mice

American Journal of Tropical Medicine and Hygiene, 1988
We examined the effect of concurrent infection with Plasmodium yoelii and Leishmania mexicana amazonensis on the course of each disease in leishmania resistant C57Bl/6 mice. P. yoelii parasitemia was greatly enhanced when L. m. amazonensis was inoculated 2 days, 3 weeks, or 12 weeks prior to the malaria. Lesions due to L. m.
Russell E Coleman, L H Semprevivo, John D Edman   +2 more
exaly   +3 more sources